Skip to content
No picture yet

Tasigna 150 mg – DIN 02368250

Tasigna is Nilotinib Hydrochloride Monohydrate 150 mg (capsule), sold in Canada. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Novartis Pharmaceuticals Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Nilotinib Hydrochloride Monohydrate 150 mg

Brand
Tasigna
Strength
150 mg
Used for
Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
Form
Capsule
Manufacturer
Novartis Pharmaceuticals Canada Inc
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02368250

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Nilotinib pills and guides

What is Nilotinib used for?

Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Adult Patients With Newly Diagnosed Ph+ CML-CP

Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP

Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02368250.
  • It names Tasigna, Nilotinib Hydrochloride Monohydrate 150 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Tasigna by Novartis Pharmaceuticals Canada Inc.

In Canada: prescription only.

Ingredients

Active: Nilotinib (Nilotinib Hydrochloride Monohydrate)

Other Nilotinib pills